Schulman Amy W's Form 4 filing
Elevance Health, Inc. (ELV) · filed Mar 23, 2026
- Accession no.
- 0001438226-26-000007
- Filed
- Mar 23, 2026
- Trade date
- Mar 12, 2026
- Filing delay
- 11 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $7.47K. It was filed 11 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schulman Amy WCIK 0001438226 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Common Stock | SSaleDisposed | −26 | $287.50 | −$7,475 | 218 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 is being filed late due to a combination of factors. The reported securities were acquired on behalf of the reporting person pursuant to broker discretionary authority prior to the reporting person joining the issuer's board. Due to administrative error, the shares were not reflected in previously reported beneficial ownership totals, including the balance reported following the equity award on February 2, 2026. The shares were sold on behalf of the reporting person pursuant to such discretionary authority, without consultation with or the consent of the reporting person, and the reporting person did not direct the specific transaction. This Form 4 is being filed promptly following discovery of the sale.